Results 41 to 50 of about 5,116,830 (334)

Dynamic gene screening enabled identification of a 10-gene panel for early detection and progression assessment of gastric cancer

open access: yesComputational and Structural Biotechnology Journal, 2023
Early diagnosis and progression assessment are critical for the timely detection and treatment of gastric cancer (GC) patients. Identification of diagnostic biomarkers for early detection of GC represents an unmet clinical need, and how these markers ...
Fei Long   +9 more
doaj   +1 more source

Liquid Biopsy Approaches for Cancer Characterization, Residual Disease Detection, and Therapy Monitoring.

open access: yesAmerican Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
Liquid biopsy encompasses a variety of molecular approaches to detect circulating tumor DNA (ctDNA) and has become a powerful tool in the diagnosis and treatment of solid tumors.
J. Aredo   +7 more
semanticscholar   +1 more source

The evolving role of liquid biopsy in lung cancer

open access: yes, 2022
Liquid biopsy has revolutionized the management of cancer patients. In particular, liquid biopsy-based testing has proven to be highly beneficial for identifying actionable cancer markers, especially when solid tissue biopsies are insufficient or ...
Umberto Malapelle   +21 more
core   +1 more source

Cost-effectiveness analysis of capecitabine maintenance therapy plus best supportive care vs. best supportive care alone as first-line treatment of newly diagnosed metastatic nasopharyngeal carcinoma

open access: yesFrontiers in Public Health, 2023
ObjectivesMaintenance therapy with capecitabine after induction chemotherapy for patients with newly diagnosed metastatic nasopharyngeal carcinoma (mNPC) has been confirmed to be effective.
Jiaqi Han   +5 more
doaj   +1 more source

Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances

open access: yesThe journal of liquid biopsy
Liquid biopsy offers a minimally invasive method for detecting and monitoring cancer, with key biomarkers including circulating tumor cells (CTCs), cell-free DNA (cfDNA), and extracellular vesicles (EVs).
Thanmayi Velpula, Viswanath Buddolla
semanticscholar   +1 more source

Fostering the implementation of liquid biopsy in clinical practice: meeting report 2024 of the European Liquid Biopsy Society (ELBS) [PDF]

open access: yes
Liquid biopsy; European liquid biopsy societyBiòpsia líquida; Societat europea de biòpsia líquidaBiopsia líquida; Sociedad europea de biopsia ...
Pantel, Klaus   +94 more
core   +1 more source

Targeting Drp1 inhibits ESCC progression via the ROS-PGC1-α-Nrf1/2 pathway

open access: yesJournal of Translational Medicine
Background Esophageal squamous cell carcinoma (ESCC) ranks among the most prevalent malignancies of the digestive tract. Due to the absence of obvious symptoms in patients with early-stage ESCC, most cases are diagnosed at advanced stages, highlighting ...
Zhixiong Jiang   +15 more
doaj   +1 more source

A scoping review of factors influencing the implementation of liquid biopsy for cancer care

open access: yesJournal of experimental & clinical cancer research : CR
Liquid biopsy (LB) offers a promising, minimally invasive alternative to traditional tissue biopsies in cancer care, enabling real-time monitoring and personalized treatment.
Samran Sheriff   +12 more
semanticscholar   +1 more source

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

open access: yesMolecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

Current Status and Future Perspectives of Liquid Biopsy in Small Cell Lung Cancer

open access: yesBiomedicines, 2021
Approximately 19% of all cancer-related deaths are due to lung cancer, which is the leading cause of mortality worldwide. Small cell lung cancer (SCLC) affects approximately 15% of patients diagnosed with lung cancer.
Patricia Mondelo-Macía   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy